MedTrace Logo

Personalized B-fructan Diet in Inflammatory Bowel Disease Patients

NCT05615779 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2025-04-06

No results posted yet for this study

Summary

This study aims to examine patient tolerability of personalized dietary fibre consumption recommendations (high-pectin diet versus high-B-fructan diet based on personalized responses), provided by an IBD dietician, based on our novel translational research findings.

Conditions

Interventions

OTHER

Placebo Comparator: Randomized pectin diet

UC and healthy control participants randomized to receive recommendations provided by a dietician increasing consumption of foods high in pectin

OTHER

Randomized B-fructan diet

UC and healthy control participants randomized to receive recommendations provided by a dietician increasing consumption of foods high in B-fructan

OTHER

Personalized pectin diet

UC and healthy control participants to receive recommendations provided by a dietician increasing consumption of foods high in pectin based on personal host (biopsy) and microbe (stool) response at baseline

OTHER

Personalized B-fructan diet

UC and healthy control participants to receive recommendations provided by a dietician increasing consumption of foods high in B-fructan based on personal host (biopsy) and microbe (stool) response at baseline

Sponsors & Collaborators

  • University of Manitoba

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
39 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-08-01
Primary Completion
2025-12-01
Completion
2025-12-01

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05615779 on ClinicalTrials.gov